nephrogenic systemic fibrosis
GPTKB entity
Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:affects |
gptkb:skin
internal organs |
| gptkbp:alsoKnownAs |
nephrogenic fibrosing dermopathy
|
| gptkbp:associatedWith |
renal insufficiency
exposure to gadolinium-based contrast agents |
| gptkbp:complication |
disability
|
| gptkbp:diagnosedBy |
clinical evaluation
skin biopsy |
| gptkbp:firstDescribed |
2000
|
| https://www.w3.org/2000/01/rdf-schema#label |
nephrogenic systemic fibrosis
|
| gptkbp:ICD-10_code |
M34.8
|
| gptkbp:prevention |
avoidance of gadolinium in at-risk patients
|
| gptkbp:riskFactor |
chronic kidney disease
dialysis |
| gptkbp:symptom |
muscle weakness
skin thickening joint contractures |
| gptkbp:treatment |
supportive care
physical therapy improved renal function |
| gptkbp:bfsParent |
gptkb:Magnevist
gptkb:gadolinium-based_contrast_agents |
| gptkbp:bfsLayer |
7
|